Psyence Biomedical (PBM) EPS (Basic) (2023 - 2025)

Psyence Biomedical's EPS (Basic) history runs 3 years deep, the most recent figure standing at -$6.35 for Q3 2025.

• On a quarterly basis, EPS (Basic) fell 25031.71% year-over-year to -$6.35 in Q3 2025; TTM through Mar 2026 was -$2.47, a 54.67% increase from a year earlier, with the FY2026 full-year figure at -$11.28, up 90.47% from the prior year.
• EPS (Basic) eased to -$6.35 in Q3 2025 per PBM's latest filing, from $0.03 in the prior quarter.
• Across five years, EPS (Basic) topped out at $0.03 in Q3 2024 and bottomed at -$2417.7 in Q1 2023.
• The 3-year median for EPS (Basic) is -$91.71 (2025), against an average of -$650.27.
• Across the five-year window, EPS (Basic) jumped 100.01% in 2024 and slumped 25031.71% in 2025, its largest moves.
• Year by year, EPS (Basic) stood at -$177.06 in 2023, then surged by 100.01% to $0.03 in 2024, then slumped by 25031.71% to -$6.35 in 2025.
• Per Business Quant, the three latest PBM EPS (Basic) figures stand at -$6.35 (Q3 2025), $0.03 (Q3 2024), and -$177.06 (Q3 2023).